Viewing Study NCT01404702


Ignite Creation Date: 2025-12-25 @ 4:05 AM
Ignite Modification Date: 2026-01-29 @ 6:17 AM
Study NCT ID: NCT01404702
Status: TERMINATED
Last Update Posted: 2014-12-02
First Post: 2011-07-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pilot Study of Zoledronic Acid and Interleukin-2 for Refractory Pediatric Neuroblastoma
Sponsor: University of Alabama at Birmingham
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroblastoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neuroblastoma View
None Pediatrics View
None Refractory View
None Immunotherapy View
None Biological therapy View
None Lymphocytes View
None Cancer View
None Bisphosphonate View